July 25, 2012 - Issue: Vol. 158, No. 112 — Daily Edition112th Congress (2011 - 2012) - 2nd Session
Constitutional Authority Statement for H.R. 6190; Congressional Record Vol. 158, No. 112
(House of Representatives - July 25, 2012)
Text available as:
Formatting necessary for an accurate reading of this text may be shown by tags (e.g., <DELETED> or <BOLD>) or may be missing from this TXT display. For complete and accurate display of this text, see the PDF.
[Page H5292] From the Congressional Record Online through the Government Publishing Office [www.gpo.gov] By Mr. BURGESS: H.R. 6190. Congress has the power to enact this legislation pursuant to the following: The attached legislation falls within Congress' authority to regulate interstate commerce as found in Article I, Section 8, clause 3 of the U.S. Constitution, which provides the authority for the Congress to ``To regulate Commerce with foreign Nations, and among the several States, and with the Indian Tribes.'' The epinephrine inhalers at issue in the attached legislation are regulated by the federal Food and Drug Administration (FDA), and the propellant at issue is regulated by the Environmental Protection Agency. The product further falls within the subject matter of an international treaty known as the Montreal Protocol on Substances that Deplete the Ozone Layer, of which the U.S. is a signatory.